ABCB10 antibody is a research tool targeting the ATP-binding cassette sub-family B member 10 (ABCB10), a mitochondrial inner membrane transporter critical for erythropoiesis, oxidative stress resistance, and mitochondrial iron metabolism . ABCB10 facilitates heme biosynthesis by stabilizing mitoferrin-1 (a mitochondrial iron importer) , exports biliverdin , and regulates cardiolipin-dependent ATPase activity . Antibodies against ABCB10 are used to detect its expression, localization, and functional interactions in cellular and disease models.
ABCB10 antibodies are validated for techniques including:
Specificity: Recognizes recombinant ABCB10 fragments (aa 450–C terminus) and native protein in mitochondrial lysates .
Cross-reactivity: Confirmed in human, mouse, rat, and pig samples .
Cardiac Dysfunction: Cardiomyocyte-specific ABCB10 knockout mice develop fibrosis, mitochondrial ROS overload, and ferroptosis due to lysosomal iron accumulation .
Erythropoiesis: ABCB10 deficiency disrupts hemoglobin synthesis, linking it to anemia pathologies .
Epitope: Most antibodies target C-terminal regions (e.g., aa 450–738) .
Buffer Stability: Store at -20°C in PBS with 0.02% sodium azide .
Dilution Range:
Ferroptosis: ABCB10 knockdown increases lysosomal Fe²⁺ and lipid peroxidation, reversed by iron chelators .
Oxidative Stress: ABCB10-null cells show elevated mitochondrial ROS and 4-HNE adducts, confirming its antioxidant role .
Therapeutic Potential: Targeting ABCB10 could mitigate ischemia-reperfusion injury or anemia .